Status:
COMPLETED
Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes
Lead Sponsor:
University of Portsmouth
Conditions:
Diabetes Type 2
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study was set up to assess the effects of different doses of aspirin when compared with placebo (dummy drug), used sequentially over a 2 week study period with a 2 week wash-out (rest period) in ...
Eligibility Criteria
Inclusion
- diabetes type 2
- age \> 18 and \< 70
- high cardiovascular risk
Exclusion
- presence of active/established cardiovascular disease (ischaemic heart disease, cerebrovascular disease or peripheral vascular disease)
- insulin treatment
- patients with known peptic ulcer disease or those on anti-coagulation
- significant renal impairment
- aspirin intolerance
- use of anticoagulants
- significant liver disease
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00898950
Start Date
August 1 2004
End Date
July 1 2006
Last Update
May 12 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Pharmacy and Biomedical Sciences, University of Posrtmouth
Portsmouth, Hampshire, United Kingdom, PO1 2DT
2
Diabetes Centre, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust
Portsmouth, Hampshire, United Kingdom, PO6 3LY